Aditya Shirali Profile
Aditya Shirali

@AdityaShiraliMD

Followers
232
Following
498
Media
11
Statuses
52

University of Florida Endocrine Surgeon, @MDAndersonNews Surgical Endocrinology Fellowship Graduate, Proud Dad and Husband.

Houston, TX
Joined August 2020
Don't wanna be here? Send us removal request.
@AdityaShiraliMD
Aditya Shirali
2 years
Great job presenting your work on thyroid cancer survivorship @tszaboyamashita! A reminder that thyroid cancer care is lifelong and requires persistent vigilance. @MDAndersonNews @AmThyroidAssn @TheAAES @DrNancyPerrier #SarahBFisherMD
Tweet media one
Tweet media two
0
3
16
@AdityaShiraliMD
Aditya Shirali
2 years
Wonderful presentation by my colleague @NaykkySinghO at @UFHealth about the use of AI in the diagnosis of hyperthyroidism. So fortunate to work with a pioneer in AI and thyroid disease! @AmThyroidAssn
Tweet media one
0
0
11
@AdityaShiraliMD
Aditya Shirali
2 years
Welcome! Looking forward to working with you all!.
@UFSurgResidents
UF Surgery Residents
2 years
Welcome to our new interns. What a stellar group we have! @UFSurgery
Tweet media one
Tweet media two
0
0
5
@AdityaShiraliMD
Aditya Shirali
2 years
Tweet media one
1
1
18
@AdityaShiraliMD
Aditya Shirali
2 years
Thank you to all my mentors at @UCLASurgeryRes @mliarispe @MDAndersonNews @UFSurgery @UFHealthCancer! Now the work begins to identify age-specific changes in immune signatures in DTC.
0
0
1
@AdityaShiraliMD
Aditya Shirali
2 years
Truly honored to be given the Paul LoGerfo Research Award at #AAES2023 to support my research as an early endocrine surgical investigator @UFSurgery! Thank you to my supportive mentors and @TheAAES for helping this dream become a reality!
Tweet media one
Tweet media two
6
6
46
@AdityaShiraliMD
Aditya Shirali
2 years
RT @RMGartlandMD: Class reunion at #AAES2023 🦏.@bhamcivilrights @TheAAES
Tweet media one
0
5
0
@AdityaShiraliMD
Aditya Shirali
2 years
Wonderful presentation by @tszaboyamashita! Pushing the boundaries for #rarecancers. Great job! @DrNancyPerrier @MDAndersonNews @TheAAES The future of endocrine surgery is bright🌟
Tweet media one
Tweet media two
1
4
18
@AdityaShiraliMD
Aditya Shirali
3 years
RT @SDreamMD: Great talk by R. Michael Tuttle on decision making for thyroid cancer treatment. So important to know the preferences of eve….
0
4
0
@AdityaShiraliMD
Aditya Shirali
3 years
A packed room! Friend and colleague @MashaLivhitsMD discussing use of molecular testing to guide surgical decision making. Fantastic talk and discussion! @michaelyehmd @JamesWuMD @MSchumm90 @AmThyroidAssn @TheAAES
Tweet media one
Tweet media two
0
1
22
@AdityaShiraliMD
Aditya Shirali
3 years
Our contemporary analysis of pheo recurrence in hereditary disease. RET M918T mutation - ⬆️ risk of recurrence. ✨Mutation status✨ is an important consideration in surgical decision making! @DrNancyPerrier @TheAAES.
@SWexner
Steven D Wexner MD, PhD
3 years
Another outstanding contribution to @SurgJournal by @DrNancyPerrier @MDAndersonNews Pheochromocytoma recurrence in hereditary disease: does a cortical-sparing technique increase recurrence rate? - Surgery @TheAAES @TheAACE @TheEndoSociety.
0
0
9
@AdityaShiraliMD
Aditya Shirali
3 years
Good discussion on treatment strategies for RAIR-DTC. Great job @AgostoSarimar!.
@AmThyroidAssn
American Thyroid Association
3 years
Read the latest blog post by Dr. @AgostoSarimar in ATA’s Thyroid Health Blog, Advanced Radioactive Iodine Refractory-Differentiated Thyroid Cancer: Current Management Perspectives. #thyroidcancer #endotwitter #medtwitter @MoffittNews.
1
0
2
@AdityaShiraliMD
Aditya Shirali
3 years
RT @AnandVaidya17: Unilateral adrenalectomy for selected/severe cases of non-lateralizing PA can provide substantial clinical benefit. This….
0
5
0
@AdityaShiraliMD
Aditya Shirali
3 years
Happy to share our work on oncocytic ACCs. No difference in disease-free survival or overall survival between OACs and conventional ACCs after matching for stage, patient age/sex and tumor functionality. #PaulGraham @DrNancyPerrier @EGrubbsMD @MDAndersonNews @TheAAES.
@AnnSurgOncol
Annals of Surgical Oncology
3 years
SEPTEMBER ISSUE: Differences in Clinicopathologic Behavior of #OncocyticAdrenocorticalNeoplasms and Conventional #AdrenocorticalCarcinomas. @McMastersKelly @SocSurgOnc
Tweet media one
0
2
8
@AdityaShiraliMD
Aditya Shirali
3 years
EMR-based interventions done by @michaelyehmd @UCLAHealth improving the detection and treatment of patients with PHPT through bioinformatics - great model for all healthcare delivery systems.
@michaelyehmd
Michael Yeh
3 years
What can be done about the underdiagnosis and undertreatment of primary #hyperparathyroidism?. A thread👇.@AcademicSurgery @TheAAES
Tweet media one
0
0
3
@AdityaShiraliMD
Aditya Shirali
3 years
Mutation status influencing prognosis in ATC further highlighting the importance of mutational testing. Great study!.
@JenniferWangMD
Jennifer R Wang, MD PhD
3 years
Published today @JCOPO_ASCO our study of 202 patients with anaplastic thyroid cancer who underwent tumor mutation testing @MDAndersonNews demonstrating that driver mutation status is significantly associated with survival outcomes and should be SOC
0
0
4
@AdityaShiraliMD
Aditya Shirali
3 years
RT @JAMASurgery: The @TheAAES Guidelines provide recommendations based on contemporary literature for clinical dilemmas in #adrenal gland s….
0
12
0
@AdityaShiraliMD
Aditya Shirali
3 years
Congratulations @MichaelLuiMD on succinctly presenting on the complex topic of normocalcemic HPT at the podium @IAESurgeons! Looking forward to seeing you soar as a future endocrine surgeon. @DrNancyPerrier @TheAAES
Tweet media one
Tweet media two
1
2
21
@AdityaShiraliMD
Aditya Shirali
3 years
RT @OSUEndoSurgBSM: Important lessons learned from radiation effects on development of thyroid cancer related to Fukushima nuclear event in….
0
3
0